Hi Ajostu,
You asked;
Do we know if there's an intrention or a nominal plan for a pediatric trial for Rett/2566 following the current phase II adult trial?
If you look at the May 2012 AGM CEO Presentation it highlights...
A second study in pediatric patients is planned for 2013. If the results of the Phase II trials are positive, we believe that a single pivotal trial in adolescents and adults and one in children would be required to submit an NDA for approval.
Regards,
Tony
retts syndrome, page-34
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
-0.540(2.81%) |
Mkt cap ! $2.383B | |||
| Open | High | Low | Value | Volume |
| $18.98 | $19.15 | $18.50 | $10.51M | 560.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $18.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.65 | 1127 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |